[
    [
        {
            "time": "2018-01-02",
            "original_text": "How AbbVie Makes its Money",
            "features": {
                "keywords": [
                    "AbbVie",
                    "business model",
                    "revenue sources"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "How AbbVie Makes its Money",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-04-05",
            "original_text": "Wall Street Recommendations for GlaxoSmithKline after 1Q18",
            "features": {
                "keywords": [
                    "GlaxoSmithKline",
                    "1Q18",
                    "recommendations",
                    "earnings report"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Wall Street Recommendations for GlaxoSmithKline after 1Q18",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-04-19",
            "original_text": "Free Research Report as Intuitive Surgical’s Quarterly Revenue Surged 25%; Adjusted EPS Soared 43%",
            "features": {
                "keywords": [
                    "Intuitive Surgical",
                    "Quarterly Revenue",
                    "EPS",
                    "Surged",
                    "Soared"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Free Research Report as Intuitive Surgical’s Quarterly Revenue Surged 25%; Adjusted EPS Soared 43%",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]